Sign Up For Life Science Leader Magazine

EXECUTIVE INTERVIEWS

GlaxoSmithKline Refocusing, Reshaping Oncology R&D

Soon after my first conversations with GlaxoSmithKline about interviewing its head of pharma R&D, the news hit. In a mega-swap of product lines with another global pharma giant, GSK gave up its entire commercial oncology portfolio to Novartis in exchange for the Swiss company’s vaccine line; at the same time, the two companies combined their consumer health units into a single business with GSK as the majority owner. Oncology was no small part of its drug division at the time, accounting for about 4 percent (about $1.5 billion) of pharmaceutical revenues before the Novartis deal.

More From Executive Interviews

THE CURRENT ISSUE

  • Am I Learning from the Failure of Others?
    Am I Learning from the Failure of Others?

    All leaders know there’s a lot to be said for the old adage, “Good judgment comes from experience, but experience comes from bad judgment.”

  • The Biosimilars Opportunity: 4 Years Of Waiting
    The Biosimilars Opportunity: 4 Years Of Waiting

    Biosimilars have been approvable in the U.S. since the 2010 passage of biosimilars-enabling legislation. However, no product applications have been approved. A few have been filed, but the industry largely remains on hold as the FDA waits to release needed guidance. Now, even the U.S. Senate is pushing the FDA to release guidance documents on biosimilar drug approvals.

  • Logistics Providers Strive To Fulfill Biopharma Needs – Specialty Companies Offer Advantages, But Get A Bad Rap On Price
    Logistics Providers Strive To Fulfill Biopharma Needs – Specialty Companies Offer Advantages, But Get A Bad Rap On Price

    According to clinicaltrials.gov, there are over 92,000 drug or biologic registered studies under way right now. Nearly one-fifth (17 percent) of the drugs currently in development are biologic-based therapeutics.

  • What A Republican Senate May Mean For Health Policy
    What A Republican Senate May Mean For Health Policy

    Just days before the election, the president’s approval ratings are at an all-time low, and Democratic Senate candidates are running against the president, with the Democratic candidate in Kentucky refusing to disclose whether she even voted for him, claiming a constitutional right to privacy. If the trajectory holds, the Republicans should take the Senate and control both houses of Congress.

  • Ask The Board
    Ask The Board

    What Is The Best Leadership Advice You Ever Received?

  • Want To Forever Alter The Course Of Your Business?
    Want To Forever Alter The Course Of Your Business?

    Have you ever had an experience that forever changed the course of your existence? I know I have.

  • 3 Lessons Pharma Can Learn From ALS Ice Bucket Fever
    3 Lessons Pharma Can Learn From ALS Ice Bucket Fever

    Regardless of your opinion of the ALS Ice Bucket Challenge (IBC), which has catapulted the ALS Association’s (ALSA’s) charitable coffers to feverish heights, there are valuable business lessons from which pharma and biotech executives can learn.

More Magazine Articles....

LIFE SCIENCE TRAINING INSTITUTE

More From LSTI

 UPCOMING EVENTS

AAPS Annual Meeting & Exposition

November 2 - 6, 2014
San Diego, CA

PACK EXPO International 2014

November 2 - 5, 2014
Chicago, IL

Chief Medical Officer West

November 3 - 4, 2014
San Francisco, CA

Process Validation: Ensuring Compliance With Multiple Standards

November 4, 2014
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

The Premarket Notification/510k Submission: Using Substantial Equivalence to your Advantage!

November 5, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
See All Events

LIFE SCIENCE SUPPLEMENTS

2014 -Trends In Clinical Research Outsourcing 2014 CMO Pharma Development & Manufacturing
 
Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in efficiently vetting potential CMO and CRO partners. In response to this input, Life Science Leader developed the Leadership Awards based on the industry leading research conducted by Nice Insight.
2014 CRO Leadership Awards 2013 CMO Leadership Awards
   
   
 

 

     
     
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

VIEW THE DIGITAL EDITION